Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 5,354 | 4,466 | 4,786 | 5,090 | 4,369 |
| Operating Income | -5,354 | -4,466 | -4,786 | -5,090 | -4,369 |
| Other Income | -72 | -2 | 51 | -578 | -60 |
| Pre-tax Income | -5,426 | -4,468 | -4,735 | -5,668 | -4,430 |
| Income Tax | 183 | 70 | 549 | 141 | 101 |
| Net Income Continuous | -5,609 | -4,538 | -5,284 | -5,809 | -4,530 |
| Net Income | $-5,609 | $-4,538 | $-5,284 | $-5,809 | $-4,530 |
| EPS Basic Total Ops | -0.13 | -0.11 | -0.15 | -0.19 | -0.16 |
| EPS Basic Continuous Ops | -0.13 | -0.11 | -0.15 | -0.19 | -0.16 |
| EPS Diluted Total Ops | -0.13 | -0.11 | -0.15 | -0.19 | -0.16 |
| EPS Diluted Continuous Ops | -0.13 | -0.11 | -0.15 | -0.19 | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.11 | -0.15 | -0.19 | -0.16 |
| EBITDA(a) | $-5,332 | $-4,438 | $-4,763 | $-5,067 | $-4,349 |